Citigroup’s Oncorus, Inc. ONCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-506
Closed -$128 5996
2022
Q4
$128 Buy
506
+15
+3% +$9 ﹤0.01% 5628
2022
Q3
$0 Sell
491
-1,635
-77% -$2.1K ﹤0.01% 6533
2022
Q2
$3K Buy
2,126
+692
+48% +$940 ﹤0.01% 5829
2022
Q1
$3K Sell
1,434
-4,426
-76% -$12.4K ﹤0.01% 6013
2021
Q4
$31K Buy
5,860
+3,531
+152% +$27.3K ﹤0.01% 5259
2021
Q3
$22K Buy
2,329
+1,357
+140% +$15.5K ﹤0.01% 5210
2021
Q2
$13K Buy
972
+474
+95% +$7.32K ﹤0.01% 5551
2021
Q1
$7K Sell
498
-727
-59% -$15.1K ﹤0.01% 5826
2020
Q4
$40K Buy
+1,225
New +$28.4K ﹤0.01% 6207

Other funds holding ONCR

Citigroup's ONCR Position: Q1 2023 in Review

Citigroup sold out of Oncorus, Inc. (ONCR) in Q1 2023, closing a stake of 506 shares — an estimated $128 sold.

Citigroup first reported a position in ONCR in Q4 2020 and held it in 9 quarters. The position peaked at $40K in Q4 2020. 32 funds tracked by Wall St. Rank hold ONCR as of Q1 2023.

  • Citigroup reported no remaining Oncorus, Inc. position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 506 Oncorus, Inc. shares in Q1 2023, an estimated $128.
  • Citigroup first reported a position in Oncorus, Inc. in Q4 2020 and held it in 9 quarters.
  • Citigroup's Oncorus, Inc. position peaked at $40K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.